[go: up one dir, main page]

FI905683L - Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi - Google Patents

Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi Download PDF

Info

Publication number
FI905683L
FI905683L FI905683A FI905683A FI905683L FI 905683 L FI905683 L FI 905683L FI 905683 A FI905683 A FI 905683A FI 905683 A FI905683 A FI 905683A FI 905683 L FI905683 L FI 905683L
Authority
FI
Finland
Prior art keywords
preparing
sustained release
release composition
composition
sustained
Prior art date
Application number
FI905683A
Other languages
English (en)
Swedish (sv)
Other versions
FI98126B (fi
FI905683A0 (fi
FI98126C (fi
Inventor
Nalinkant Chunilal Damani
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27031904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI905683(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI905683A0 publication Critical patent/FI905683A0/fi
Publication of FI905683L publication Critical patent/FI905683L/fi
Publication of FI98126B publication Critical patent/FI98126B/fi
Application granted granted Critical
Publication of FI98126C publication Critical patent/FI98126C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI905683A 1989-11-17 1990-11-16 Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi FI98126C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43906689A 1989-11-17 1989-11-17
US43906689 1989-11-17
US07/573,604 US5198220A (en) 1989-11-17 1990-08-24 Sustained release compositions for treating periodontal disease
US57360490 1990-08-24

Publications (4)

Publication Number Publication Date
FI905683A0 FI905683A0 (fi) 1990-11-16
FI905683L true FI905683L (fi) 1991-05-18
FI98126B FI98126B (fi) 1997-01-15
FI98126C FI98126C (fi) 1997-04-25

Family

ID=27031904

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905683A FI98126C (fi) 1989-11-17 1990-11-16 Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi

Country Status (14)

Country Link
US (1) US5198220A (fi)
EP (1) EP0430474B1 (fi)
JP (1) JP3051154B2 (fi)
KR (1) KR0156917B1 (fi)
AT (1) ATE118170T1 (fi)
AU (1) AU648278B2 (fi)
CA (1) CA2029046C (fi)
DE (1) DE69016755T2 (fi)
DK (1) DK0430474T3 (fi)
ES (1) ES2067696T3 (fi)
FI (1) FI98126C (fi)
GR (1) GR3015027T3 (fi)
IE (1) IE66371B1 (fi)
NZ (1) NZ236113A (fi)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
FR2691360B1 (fr) * 1992-05-20 1995-06-30 3P Agence Conseil Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication.
NZ247712A (en) * 1992-06-19 1995-04-27 Colgate Palmolive Co Oral composition comprising an anti-bacterial compound, a water-insoluble biodegradable polymer, and an organic solvent
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US6001895A (en) * 1993-03-22 1999-12-14 Johnson & Johnson Medical, Inc. Composite surgical material
US6015844A (en) * 1993-03-22 2000-01-18 Johnson & Johnson Medical, Inc. Composite surgical material
GB2280850B (en) * 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
AU7957994A (en) * 1993-10-01 1995-05-01 Procter & Gamble Company, The Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5639466A (en) * 1994-02-24 1997-06-17 Chronopol, Inc. Method for packaging foodstuffs
PL179910B1 (pl) 1994-05-06 2000-11-30 Pfizer Postac dawkowania o kontrolowanym uwalnianiu zawierajaca azytromycyne PL PL PL PL PL PL PL PL
JPH08113534A (ja) * 1994-10-17 1996-05-07 Ichiro Umeuchi 歯周病治療器具
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6551610B2 (en) 1995-04-13 2003-04-22 Poly-Med, Inc. Multifaceted compositions for post-surgical adhesion prevention
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
ATE267587T1 (de) 1995-06-09 2004-06-15 Euro Celtique Sa Formulierungen und verfahren für eine verlängerte lokalanästhesie
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
AU733867B2 (en) 1996-06-24 2001-05-31 Euro-Celtique S.A. Methods for providing safe local anesthesia
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
CN1108149C (zh) * 1997-03-18 2003-05-14 新时代株式会社 固体微粒形成用组合物
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
EP1009390A4 (en) 1997-07-02 2004-05-06 Euro Celtique Sa LONG-EFFECT ANESTHESIA INJECTED IN JOINT AND BODY SPACES
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6605294B2 (en) 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6514534B1 (en) * 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
WO2000009199A1 (en) * 1998-08-14 2000-02-24 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6566144B1 (en) 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
US6626870B1 (en) 2000-03-27 2003-09-30 Artix Laboratories, Inc. Stoppering method to maintain sterility
PE20020102A1 (es) 2000-06-30 2002-03-06 Procter & Gamble Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
AU2001271545A1 (en) * 2000-06-30 2002-01-14 The Procter And Gamble Company Promoting whole body health
US8470359B2 (en) 2000-11-13 2013-06-25 Qlt Usa, Inc. Sustained release polymer
WO2002058670A1 (en) * 2001-01-25 2002-08-01 Euroceltique S.A. Local anesthetic, and method of use
JP2003231622A (ja) * 2001-12-04 2003-08-19 Kao Corp 口腔用組成物
WO2004050023A2 (en) 2002-11-27 2004-06-17 Dmi Biosciences, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
KR20060088543A (ko) * 2003-09-25 2006-08-04 디엠아이 바이오사이언스 인코포레이티드 앤-아실-엘-아스파틱산을 이용하는 방법 및 제품
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US20050125033A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Wound closure apparatus
US20050125015A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Tissue-handling apparatus, system and method
BRPI0514098B1 (pt) * 2004-08-13 2021-01-19 Intervet International B. V. composição farmacêutica tópica para o tratamento de uma infecção ótica
DK1791791T3 (da) * 2004-09-27 2019-08-26 Special Water Patents B V Fremgangsmåder og sammensætninger til behandling af vand
US7611494B2 (en) * 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
EP1910080A4 (en) * 2005-07-28 2010-10-13 Univ Indiana Res & Tech Corp NIOBOXIDE COMPOUNDS, NANOSTRUCTURES, BIOACTIVE FORMS AND THEIR USE
EP1948236B1 (en) 2005-09-27 2021-03-03 Special Water Patents B.V. Methods and compositions for treatment of skin
WO2007089894A2 (en) * 2006-01-31 2007-08-09 Indiana University Research & Technology Corporation Materials and methods for manufacturing amorphous tricalcium phosphate and metal oxide alloys of amorphous tricalcium phosphate and methods of using the same
JP2010508947A (ja) 2006-11-13 2010-03-25 ザ プロクター アンド ギャンブル カンパニー 口腔内の状態を検出する製品及び方法
US8298516B2 (en) * 2006-12-22 2012-10-30 Douglas Anderson Calculus dissolving dental composition and methods for using same
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms
EP2268199B1 (en) * 2008-05-02 2018-10-17 The Procter and Gamble Company Products and methods for disclosing conditions in the oral cavity
WO2010068428A1 (en) 2008-11-25 2010-06-17 The Procter & Gamble Company Oral care compositions with improved aesthetics and fused silica
CA2750242C (en) * 2009-02-12 2018-05-22 Incept, Llc Drug delivery through hydrogel plugs
DK3045043T3 (da) 2009-02-26 2020-08-03 Relmada Therapeutics Inc Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
US8980229B2 (en) 2009-04-01 2015-03-17 Colgate-Palmolive Company Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
US8434489B2 (en) 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
MX343550B (es) 2010-04-01 2016-11-08 The Procter & Gamble Company * Control del mal olor en toda la boca con una combinacion de agentes antibacterianos y desodorizantes.
WO2012012385A2 (en) 2010-07-19 2012-01-26 The Procter & Gamble Company Compositions comprising derivatives of essential oil compounds and use in personal care products
US20120076734A1 (en) * 2010-09-15 2012-03-29 Jacob Olson Radiopaque antibiotic dental paste and uses thereof
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
CN109200013A (zh) 2011-12-05 2019-01-15 因赛普特有限责任公司 医用有机凝胶方法和组合物
US20130344120A1 (en) 2012-06-21 2013-12-26 Douglas Craig Scott Mouth Rinse Emulsions
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
RU2608129C2 (ru) 2012-11-05 2017-01-13 Дзе Проктер Энд Гэмбл Компани Термически обработанная осажденная двуокись кремния
US9827082B2 (en) 2013-02-26 2017-11-28 Orthoaccel Technologies, Inc. Fluoride releasing bite plate
BR112015025558A2 (pt) 2013-04-10 2017-07-18 Procter & Gamble composições para tratamento bucal contendo partículas de poliorgano silsesquioxano
MX2015014324A (es) 2013-04-10 2015-12-08 Procter & Gamble Composiciones para el cuidado bucal que contienen particulas de poliorganosilsesquioxano.
MX2015014322A (es) 2013-04-10 2015-12-08 Procter & Gamble Composiciones pare el cuidado bucal que contienen particulas de poliorganosilsesquioxano.
US9572212B2 (en) 2014-05-21 2017-02-14 Lumens Co., Ltd. LED lighting device using AC power supply
ES2913120T3 (es) 2015-08-04 2022-05-31 Isp Investments Llc Polímeros derivados de éteres de alcohol vinílico aminofuncionales y aplicaciones de los mismos
EP3389599B1 (en) 2015-12-15 2024-07-17 John A. Gontarz Oral care formulation and method for the removal of tartar and plaque from teeth
EP3658110B1 (en) 2017-12-20 2023-04-05 Firmenich SA Oral care compositions
BR112020003125B1 (pt) 2017-12-21 2023-11-14 Firmenich S.A Composições de resfriamento e realçadoras de aroma
EP3958983A1 (en) 2019-04-26 2022-03-02 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
MX2022003494A (es) 2019-10-17 2022-04-25 Givaudan Sa Azacilos sustituidos como moduladores del miembro 8 de melastatina de potencial receptor transitorio (trmp8).
WO2021102896A1 (en) 2019-11-29 2021-06-03 Givaudan Sa Organic compounds
WO2021174475A1 (en) 2020-03-05 2021-09-10 Givaudan Sa Organic compounds
GB202012170D0 (en) 2020-08-05 2020-09-16 Givaudan Sa Organic compounds
WO2022170519A1 (en) 2021-02-09 2022-08-18 Givaudan Sa Organic compounds
GB202105661D0 (en) 2021-04-21 2021-06-02 Givaudan Sa Organic compounds
GB202303792D0 (en) 2023-03-15 2023-04-26 Givaudan Sa Cosmetic composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608057A (en) * 1967-10-03 1971-09-21 Amicon Corp Process for making contact lenses
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US4048256A (en) * 1976-06-01 1977-09-13 American Cyanamid Company Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product
US4328204A (en) * 1977-03-02 1982-05-04 Ethicon, Inc. Absorbable polymer-drug compounds and method for making same
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
US4624256A (en) * 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
JPH0617300B2 (ja) * 1986-09-22 1994-03-09 サンスタ−株式会社 歯周疾患治療用組成物
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JPH0645535B2 (ja) * 1987-05-20 1994-06-15 サンスタ−株式会社 歯槽骨代謝治療用組成物
IL86802A0 (en) * 1987-06-30 1988-11-30 Vipont Pharma Drug delivery devices
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5005074A (en) * 1989-11-17 1991-04-02 Rca Licensing Corporation Adaptive multistandard video comb filter

Also Published As

Publication number Publication date
KR910009243A (ko) 1991-06-28
JPH03271219A (ja) 1991-12-03
FI98126B (fi) 1997-01-15
ES2067696T3 (es) 1995-04-01
CA2029046C (en) 1995-03-28
JP3051154B2 (ja) 2000-06-12
DE69016755T2 (de) 1995-09-21
EP0430474A1 (en) 1991-06-05
FI905683A0 (fi) 1990-11-16
AU648278B2 (en) 1994-04-21
NZ236113A (en) 1993-05-26
FI98126C (fi) 1997-04-25
DK0430474T3 (da) 1995-04-03
KR0156917B1 (ko) 1998-11-16
AU6667690A (en) 1991-05-23
GR3015027T3 (en) 1995-05-31
EP0430474B1 (en) 1995-02-08
IE904147A1 (en) 1991-05-22
CA2029046A1 (en) 1991-05-18
DE69016755D1 (de) 1995-03-23
US5198220A (en) 1993-03-30
ATE118170T1 (de) 1995-02-15
IE66371B1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
FI905683L (fi) Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi
FI885884L (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI906249A7 (fi) Menetelmä farmaseuttisen seoksen valmistamiseksi
FI914398A7 (fi) Menetelmä farmaseuttisen kokoonpanon valmistamiseksi
FI870588A7 (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
FI20031891L (fi) Menetelmä hallitusti vapautuvan formulaation valmistamiseksi
FI990251L (fi) Menetelmä purukumikoostumuksen valmistamiseksi
FI905682L (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI914354L (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
FI892054A7 (fi) Menetelmä nitroglyseriiniä luovuttavan laastarin valmistamiseksi
DK0429760T4 (da) Fremgangsmåde til fremstilling af et aromatiseringsmiddel
FI912109A7 (fi) Menetelmä polymeerikoostumuksen valmistamiseksi
FI913811L (fi) Menetelmä silmätipoiksi tarkoitetun koostumuksen valmistamiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI895766A7 (fi) Menetelmä uusien lysosfingolipidien valmistamiseksi
FI905681L (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
FI932552A7 (fi) Menetelmä säädellyn vapautumisen kiinteän yksikköannostusmuodon valmis tamiseksi
FI903906A7 (fi) Menetelmä neoalkyylitriolitriestereiden valmistamiseksi
FI20001776L (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI902117A7 (fi) Menetelmä polyketonien valmistamiseksi
FI913554L (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
FI896231A7 (fi) Menetelmä L-alaniinin valmistamiseksi
FI935019L (fi) Menetelmä klodronaattivalmisteen valmistamiseksi
FI895800A7 (fi) Menetelmä uusien a-syano-b-oksopropioniamidien valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE PROCTER & GAMBLE COMPANY